secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001140361-24-003165
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech CMO Lauren Wood retires; Kirk Shepard appointed as new CMO
----------------------------------------------------------------------

- Lauren V. Wood, M.D. retired as CMO effective January 22, 2024; departure not related to any disagreement.
- Kirk V. Shepard, M.D. appointed as CMO effective January 22, 2024; board-certified oncologist with >30 years industry experience.
- Inducement Plan amended to increase reserved shares from 1,100,000 to 2,100,000 shares of common stock.
- Dr. Shepard granted nonstatutory stock options to purchase 200,000 shares at $4.49 (closing price on grant date).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036124003165/0001140361-24-003165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036124003165/ef20019392_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-003165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer